RU2010128627A - 2-Ethyl-6-methyl-3-hydroxypyridine salt with nicotinic acid, possessing hypoglycemic, hypolipidemic and neuroprotective activity, and a method for its preparation - Google Patents
2-Ethyl-6-methyl-3-hydroxypyridine salt with nicotinic acid, possessing hypoglycemic, hypolipidemic and neuroprotective activity, and a method for its preparation Download PDFInfo
- Publication number
- RU2010128627A RU2010128627A RU2010128627/04A RU2010128627A RU2010128627A RU 2010128627 A RU2010128627 A RU 2010128627A RU 2010128627/04 A RU2010128627/04 A RU 2010128627/04A RU 2010128627 A RU2010128627 A RU 2010128627A RU 2010128627 A RU2010128627 A RU 2010128627A
- Authority
- RU
- Russia
- Prior art keywords
- hydroxypyridine
- ethyl
- methyl
- nicotinic acid
- dose
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Соль 2-этил-6-метил-3-гидроксипиридина с никотиновой кислотой формулы (1) ! ! обладающая гипогликемической, гиполипидемической и нейропротекторной активностью. ! 2. Способ получения соединения формулы (1) по п.1, включающий взаимодействие 2-этил-6-метил-3-гидроксипиридина с никотиновой кислотой в среде растворителя при перемешивании реагентов и кипячении с последующей отгонкой растворителя и перекристаллизацией выпавшего целевого продукта. ! 3. Способ коррекции метаболических нарушений при сахарном диабете с экзогенной гиперхолестеринемией, включая коррекцию дислипидемических нарушений и гипергликемии, заключающийся в том, что вначале моделируют экспериментальный сахарный диабет однократным внутрибрюшинным введением аллоксана в дозе 135 мг/кг, через 14 сут после моделирования лабораторным животным в течение 14 дней вводят один раз в день перорально масляную суспензию холестерина из расчета 40 мг/кг, предварительно растворив в 0,5 мл растительного масла с добавлением витамина Д в дозе 12500 ЕД/кг, и внутримышечно соль 2-этил-6-метил-3-гидроксипиридина с никотиновой кислотой в дозе 50 мг/кг. ! 4. Способ коррекции морфофункциональных нарушений в головном мозге при острой ишемии, заключающийся в том, что после моделирования аллоксанового сахарного диабета с экзогенной гиперхолестеринемией в течение 4 недель моделируют острую ишемию головного мозга путем перевязки общих сонных артерий под ингаляционным эфирным наркозом, при этом соль 2-этил-6-метил-3-гидроксипиридина с никотиновой кислотой в дозе 100 мг/кг вводят лабораторным животным внутрибрюшинно ежедневно в течение 3 суток до моделирования ишемического инсульта, ч� 1. Salt of 2-ethyl-6-methyl-3-hydroxypyridine with nicotinic acid of the formula (1)! ! possessing hypoglycemic, hypolipidemic and neuroprotective activity. ! 2. A method of obtaining a compound of formula (1) according to claim 1, comprising reacting 2-ethyl-6-methyl-3-hydroxypyridine with nicotinic acid in a solvent medium with stirring of the reagents and boiling, followed by distillation of the solvent and recrystallization of the precipitated target product. ! 3. A method for the correction of metabolic disorders in diabetes mellitus with exogenous hypercholesterolemia, including the correction of dyslipidemic disorders and hyperglycemia, which consists in first simulating experimental diabetes mellitus with a single intraperitoneal injection of alloxan at a dose of 135 mg / kg, 14 days after modeling by laboratory animals during For 14 days, an oily suspension of cholesterol is administered once a day at a rate of 40 mg / kg, previously dissolved in 0.5 ml of vegetable oil with the addition of vitamin at a dose of 12500 U / kg and intramuscularly salt of 2-ethyl-6-methyl-3-hydroxypyridine with nicotinic acid in a dose of 50 mg / kg. ! 4. A method for the correction of morphofunctional disorders in the brain in acute ischemia, which consists in the fact that after modeling alloxan diabetes with exogenous hypercholesterolemia, acute cerebral ischemia is simulated for 4 weeks by ligation of the common carotid arteries under inhaled ether anesthesia, with salt 2- ethyl 6-methyl-3-hydroxypyridine with nicotinic acid at a dose of 100 mg / kg was administered intraperitoneally to laboratory animals daily for 3 days before the simulation of ischemic stroke,
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010128627/04A RU2454406C2 (en) | 2010-07-09 | 2010-07-09 | 2-ethyl-6-methyl-3-hydroxypyridine and nicotinic acid salt, having hypoglycemic, hypolipidemic and neuroprotective activity and synthesis method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010128627/04A RU2454406C2 (en) | 2010-07-09 | 2010-07-09 | 2-ethyl-6-methyl-3-hydroxypyridine and nicotinic acid salt, having hypoglycemic, hypolipidemic and neuroprotective activity and synthesis method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2010128627A true RU2010128627A (en) | 2012-01-20 |
| RU2454406C2 RU2454406C2 (en) | 2012-06-27 |
Family
ID=45785192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010128627/04A RU2454406C2 (en) | 2010-07-09 | 2010-07-09 | 2-ethyl-6-methyl-3-hydroxypyridine and nicotinic acid salt, having hypoglycemic, hypolipidemic and neuroprotective activity and synthesis method thereof |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2454406C2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2663836C1 (en) * | 2017-12-14 | 2018-08-10 | Акционерное общество "Мадмит трейд" | L-enantymer of 2-ethyl-6-methyl-3-hydroxypiridinium hydroxybutandioate possessing cerebroprotective activity |
| RU2683770C1 (en) * | 2018-01-23 | 2019-04-02 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" | Method for producing liposomal form of 2-ethyl-6-methyl-3-hydroxypyridine salt with nicotin acid, using it for improving microcirculation in skin |
| RU2743923C1 (en) * | 2020-05-29 | 2021-03-01 | Общество с ограниченной ответственностью "Мадмит" | Novel 3-hydroxypyridine derivative having lipid regulating activity |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2284993C2 (en) * | 2002-06-14 | 2006-10-10 | Леонид Дмитриевич Смирнов | 2-ethyl-6-methyl-3-oxypyrodine salts with organic carboxylic acids possessing anxiolytic, antidepressive, antihypoxic, anti-amnestic and anti-oxidative activity and method for their preparing |
| RU2377237C1 (en) * | 2008-04-10 | 2009-12-27 | Закрытое акционерное общество "Медимэкс" (ЗАО "Медимэкс") | 2-ethyl-6-methyl-3-hydroxyliridiniumhydroxybutanedioat expressing anti-ishemic, cerebroprotective, neurotropic and lipid-regulating activity, pharmaceutical compositions and medical product |
-
2010
- 2010-07-09 RU RU2010128627/04A patent/RU2454406C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2454406C2 (en) | 2012-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69912581T2 (en) | BIARYL ACETIC ACID DERIVATIVES AND THEIR USE AS COX-2 INHIBITORS | |
| JP2017508794A5 (en) | ||
| CA2681639A1 (en) | Compounds and methods for treatment of disorders associated with er stress | |
| CA2816949C (en) | Methods of treatment using lipid compounds | |
| JP2017508795A5 (en) | ||
| EP3388424B1 (en) | Method for preparing anti-heart-failure medicine lcz696 | |
| CN111285829A (en) | PPAR gamma/delta dual agonist, preparation method thereof and application thereof as medicament | |
| RU2010128627A (en) | 2-Ethyl-6-methyl-3-hydroxypyridine salt with nicotinic acid, possessing hypoglycemic, hypolipidemic and neuroprotective activity, and a method for its preparation | |
| BRPI0612475B8 (en) | methods for preparing a compound | |
| RU2015134420A (en) | CRYSTAL FORMS of {[1-CYANO-5- (4-CHLOROPHENOXIDE) -4-HYDROXIDE-Isoquinoline-3-CARBONIL] -AMINO} -ACETRIC ACID | |
| CA2998875A1 (en) | Carborane compounds and methods of use thereof | |
| CA2622452A1 (en) | Hemodynamics improving agent | |
| Bon et al. | One and Two-Carbon Homologation of Primary and Secondary Alcohols to Corresponding Carboxylic Esters Using β-Carbonyl BT Sulfones as a Common Intermediate | |
| CA2936707A1 (en) | Diaminoguanidine derivatives and application thereof in preparation of animal growth promoters used in feed | |
| Timmer et al. | Rapid synthesis of 1-deoxygalactonojirimycin using a carbamate annulation | |
| CN104326950A (en) | Phenoxyacetic acid derivative, preparation process thereof and use thereof as medicaments | |
| PL1940772T3 (en) | Novel method for preparing quaternary acid and ammonium salts | |
| RU2011114776A (en) | Ethyl 1,6-diaryl-4-aroyl-3-hydroxy-2-oxo-8-phenyl-1,7-diazaspiro [4.4] nona-3,6,8-trien-9-carboxylates and a process for the preparation thereof | |
| RU2010148530A (en) | 4-Trimethylammoniobutyrates as CPT2 Inhibitors | |
| CN106999458A (en) | Aromatic compounds and pharmaceutical composition are substituted for prevent and treat diabetes | |
| BR112019025120A2 (en) | PIRAZOL DERIVATIVE, METHOD OF PREPARATION AND USE OF THE SAME | |
| CN106146488B (en) | The Preparation method and use of the double-functional group berberinc derivate of 9- substitutions | |
| CN104829497B (en) | A kind of biguanide compound and its preparation method and application | |
| RU2006113431A (en) | 2-Ethyl-6-methyl-3-hydroxypyridine n-acetylcysteinate possessing antioxidant, hypoglycemic, hypolipidemic, and anti-shock properties | |
| CN106008609A (en) | Cyclometalated platinum complex and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20120710 |